Zoetis Inc.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattl…

Drug Manufacturers - Specialty & Generic

US, Parsippany [HQ]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about Zoetis Inc.'s gradings, price targets and earnings estimates.

Earnings

See the historical earnings and what wall street analysts forecasted and
forecast for future earnings.

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.
FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2014	1.0100	1.390	4,561	4,506	504	546	889	1,068	820	910	1,613	1,535
2015	1.1600	1.728	4,785	4,737	583	276	1,022	724	969	904	1,643	1,306
2016	0.6800	1.943	4,765	4,885	339	728	1,050	1,451	1,070	1,243	1,532	1,218
2017	1.6600	2.368	4,888	5,250	821	821	1,484	1,848	1,397	1,641	1,364	1,269
2018	1.7600	3.116	5,307	5,789	864	1,322	1,810	2,049	1,725	1,742	1,334	1,379
2019	2.9600	3.609	5,825	6,225	1,428	1,381	2,081	2,241	1,881	1,856	1,484	1,508
2020	3.1400	3.796	6,260	6,600	1,500	1,334	2,230	1,725	2,018	1,843	1,638	1,424
2021	3.4400	4.668	6,675	7,743	1,638	1,767	2,729	2,749	2,269	2,436	1,726	1,765
2022	4.2900	4.880	7,776	8,042	2,037	2,012	2,916	3,116	2,803	2,795	2,001	2,019
2023	4.5100	5.411	8,080	8,522	2,114	2,344	3,038	3,428	2,928	3,074	2,009	2,221
2024	5.0800	5.850	8,544	9,229	2,344	2,704	3,560	3,567	3,069	3,005	2,151	2,358
2025	-	6.409	-	9,731	-	2,948	-	3,761	-	3,169	-	2,487
2026	-	7.111	-	10,420	-	2.F12X/td>	-	2.F121/td>	-	2.F121	-	2.F121
2027	-	7.894	-	11,049	-	1.F13X/td>	-	1.F131/td>	-	1.F131	-	1.F131
2028	-	8.443	-	11,408	-	0.F14X/td>	-	0.F141/td>	-	0.F141	-	0.F141

Institutional Sentiment

Wall Street · Earnings · Institutional Sentiment

The institutional sentiment measures the direction of new stock gradings
and price targets while comparing them Year-over-Year. We've limited the grading institutes to those we see as top-tier and update this data every month.

Morgan Stanley

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

JP Morgan Chase

1Y Ago:

Overweight

Prev. Grade

Overweight

Dec. 1, 2024

Overweight

Citigroup

1Y Ago:

n/a

Prev. Grade

n/a

Latest

n/a

Overall Consensus

Here we aggregate the price targets and gradings of all IBs/AMCs/Brokerage firms inside our database to draw a bigger picture.

Grading Consensus

Click to each, to see the grade

Price Target Consensus

-33.276% $54.41 · MISS

Nov. 6, 2024

Price Then

$175.27

Price Target

$217.92

Price Now

$163.51